Frontiers | Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
Vaccines | Free Full-Text | Overview of Neutralizing Antibodies and Their Potential in COVID-19
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
Research and Development Progress of a SARS-CoV-2 Neutralizing Antibody
Heterophilic Blocking Reagents (HAMA Blocker) - dianova
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: Trends in Immunology
Non-neutralizing antibodies and vaccine-induced protection against HIV | Future HIV Therapy
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
What is antibody therapy?
Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting - Chemical Science (RSC Publishing)
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 | bioRxiv
Neutralizing Antibody - an overview | ScienceDirect Topics
COVID-19 Neutralizing Antibody Test | anptech
R&D Systems Blocking/Neutralizing Antibodies: R&D Systems
Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy | ACS Central Science
LIBRA-seq: Accelerating antibody discovery
Broadly neutralizing antibodies to prevent HIV-1 | Science
Checkpoint blocking antibodies in cancer immunotherapy - ScienceDirect
Measuring Neutralizing Ability to SARS-CoV-2 Variant Spike Proteins | Bio-Techne
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect
Peptide Blocking: Novus Biologicals
Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction | PLOS ONE
Anti-mCD25 | PC-61.5.3 & 7D4| InvivoGen
The potential danger of suboptimal antibody responses in COVID-19 | Nature Reviews Immunology
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect
